Collagen Markers in Heart Failure and Preserved Ejection Fraction

NCT01677494 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2014-09-03

No results posted yet for this study

Summary

Assessment of cardiac fibrosis by echocardiography (Speckle tracking), IRM (late-enhancement imaging), biology (markers of collagen turn-over) and proteomics

Conditions

  • Left-sided Congestive Heart Failure

Sponsors & Collaborators

  • University Hospital, Rouen

    lead OTHER

Principal Investigators

  • Fabrice Bauer, MD, PhD · University Hospital, Rouen

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2013-08-31
Completion
2013-08-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01677494 on ClinicalTrials.gov